REQUEST A DEMO
Total
USD $0.00
Search more companies

BC World Pharm Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medicinal and Botanical Manufacturing
Full name: BC World Pharm Co., Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company's products mainly consist of anesthetic drugs, circulating system drugs, antibiotics, and other prescription drugs. The Company was established on March 19, 1980. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 15, 2014.

Headquarters
872-23, Yeojunam-Ro, Ganam-Eup, Yeoju-Si, Gyeonggi-Do
Yeongju; Gyeongsangbuk;

Contact Details: Purchase the BC World Pharm Co., Ltd. report to view the information.

Website: http://www.bcwp.co.kr

Basic Information
Total Employees:
Purchase the BC World Pharm Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the BC World Pharm Co., Ltd. report to view the information.
Registered Capital:
Purchase the BC World Pharm Co., Ltd. report to view the information.
Financial Auditors:
Purchase the BC World Pharm Co., Ltd. report to view the information.
Incorporation Date:
June 10, 1980
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
34%
Purchase this report to view the information.
1.9%
Purchase this report to view the information.
1.8%
Subsidiaries
(주)비씨월드헬스케어
51%
Company Performance
Financial values in the chart are available after BC World Pharm Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
3.31%
Total operating revenue
3.28%
Operating profit (EBIT)
377.08%
EBITDA
50.6%
Net Profit (Loss) for the Period
4738.58%
Total assets
0.58%
Total equity
3.03%
Operating Profit Margin (ROS)
6.45%
Net Profit Margin
3.77%
Return on Equity (ROE)
3.54%
Debt to Equity Ratio
-6.6%
Quick Ratio
0.02%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?